Computer-Conceived Chemical Compounds Make A Debut

The fledgling field of computer drug design, viewed skeptically by some scientists, gained dramatic validation when scientists from Agouron Pharmaceuticals Inc. reported at a March 18 cancer symposium in Amsterdam that they have created a new compound. Agouron claims the compound, dubbed AG-331, demonstrates "significant anti-tumor activity" in animal tests. "This is a completely novel chemical entity that was not found in nature," says Mike Varney, a computational chemist at San Diego-based

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"This is a completely novel chemical entity that was not found in nature," says Mike Varney, a computational chemist at San Diego-based Agouron. "It is not a biotechnology product. It is not a product cloned or screened. We truly built it, atom by atom."

The study of how the shapes of molecules influence their propensity to react is an interdisciplinary field sometimes called molecular recognition. Working under this broad heading are structural and cell biologists; computer scientists; and theoretical, experimental, and computational chemists. Computational chemists owe much of their progress in developing software for modeling molecules to the seminal work of Nobel laureate Donald Cram, who in the early 1970s began making models of molecules with the only tools then available--hand-held models in which balls depicted the atoms and sticks represented the bonds between them. After synthesizing the molecules conceived in this fashion, Cram then reacted them with a target ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Tom Abate

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development